- Home
- NUS vs TP Comparison
NUS vs TP Comparison
Compare NUS & TP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NUS | TP |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.5M | 246.4M |
| IPO Year | 1996 | 2026 |
Fundamental Metrics
Financial Performance| Metric | NUS | TP |
|---|---|---|
| Price | $4.99 | $8.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.66 |
| AVG Volume (30 Days) | ★ 426.5K | 16.9K |
| Earning Date | 11-05-2026 | 08-20-2026 |
| Dividend Yield | ★ 4.67% | N/A |
| EPS Growth | ★ 207.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,176,718,000.00 | N/A |
| Revenue This Year | N/A | $67.70 |
| Revenue Next Year | $11.95 | $27.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 48.98 | N/A |
| 52 Week Low | $4.45 | $6.10 |
| 52 Week High | $11.67 | $12.14 |
Technical Indicators
Market Signals| Indicator | NUS | TP |
|---|---|---|
| Relative Strength Index (RSI) | 58.70 | 52.81 |
| Support Level | $4.95 | $7.96 |
| Resistance Level | $5.45 | $9.48 |
| Average True Range (ATR) | 0.15 | 0.96 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 61.90 | 54.13 |
Price Performance
Historical ComparisonAbout NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.